Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
2.760
-0.100 (-3.50%)
Dec 3, 2024, 2:02 PM EST - Market open
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $212.15 million as of December 3, 2024. Its market cap has increased by 135.62% in one year.
Market Cap
212.15M
Enterprise Value
155.46M
1-Year Change
135.62%
Ranking
Category
Stock Price
$2.76
Market Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $212.15M, an increase of 149.62%. That is a compound annual growth rate of 17.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2024 | 219.84M | 156.91% |
| Dec 29, 2023 | 85.57M | -26.01% |
| Dec 30, 2022 | 115.65M | 472.04% |
| Dec 31, 2021 | 20.22M | -54.55% |
| Dec 31, 2020 | 44.48M | -33.49% |
| Dec 31, 2019 | 66.88M | -21.31% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sera Prognostics | 227.63M |
| SOPHiA GENETICS | 226.56M |
| MacroGenics | 225.32M |
| Compass Therapeutics | 224.27M |
| Accuray | 224.26M |
| Utah Medical Products | 221.30M |
| Cidara Therapeutics | 221.08M |
| Inhibrx Biosciences | 220.90M |